📊 CURLF Key Takeaways
Is Curaleaf Holdings, Inc. (CURLF) a Good Investment?
Insufficient financial data availability prevents fundamental analysis. With only 1 metric available and no recent income statement, balance sheet, or cash flow data, the company's financial health, profitability, and operational performance cannot be assessed. The lack of data freshness and 0 insider activity in 90 days raises concerns about reporting compliance and management confidence.
Curaleaf’s fundamentals are mixed: the company remains operationally resilient with 50% gross margin, positive operating income from continuing operations, and strong operating cash flow, but overall revenue declined 5% in 2025 and net losses remain large. International growth is a real offset to domestic pressure, yet the balance sheet still carries meaningful leverage, large intangible asset exposure, and a rapidly growing uncertain tax liability tied to Section 280E positions.
Why Buy Curaleaf Holdings, Inc. Stock? CURLF Key Strengths
- Operates in medicinal chemicals and botanical products sector with potential growth
- OTC listing suggests market awareness
- CIK registration indicates SEC filing compliance capability
- Gross margin improved to 50% in 2025 from 48% in 2024, showing better production efficiency and cost control
- Operating cash flow from continuing operations remained strong at about $152 million, supporting capital spending and debt servicing
- International revenue grew 63% year over year, providing a higher-quality growth engine while domestic revenue weakened
CURLF Stock Risks: Curaleaf Holdings, Inc. Investment Risks
- Critical absence of financial data - no revenue, income, assets, or cash flow reporting visible
- Data freshness shows None - indicates outdated or missing SEC filings
- No insider activity in 90 days suggests potential loss of management confidence
- Unable to assess profitability, liquidity, leverage, or operational efficiency
- Only 1 metric available out of comprehensive required set
- Net loss attributable to Curaleaf widened to about $231 million, indicating that operating profitability is still not translating into bottom-line earnings
- Uncertain tax position rose to roughly $532 million, creating major regulatory and cash flow risk if the company’s tax position is challenged
- Balance sheet quality is pressured by high liabilities and very large goodwill and intangible balances, which raise financial and impairment risk
Key Metrics to Watch
- Latest 10-Q and 10-K filings for complete financial statements
- Revenue trends and gross margin sustainability
- Operating cash flow and free cash flow generation
- Balance sheet strength - debt levels and working capital adequacy
- Insider trading activity as confidence indicator
- Domestic revenue stabilization and segment margin trend
- Uncertain tax position and cash taxes paid under Section 280E-related developments
Curaleaf Holdings, Inc. (CURLF) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
CURLF Profit Margin, ROE & Profitability Analysis
CURLF vs Materials Sector: How Curaleaf Holdings, Inc. Compares
How Curaleaf Holdings, Inc. compares to Materials sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Curaleaf Holdings, Inc. Stock Overvalued? CURLF Valuation Analysis 2026
Based on fundamental analysis, Curaleaf Holdings, Inc. has mixed fundamental signals relative to the Materials sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Curaleaf Holdings, Inc. Balance Sheet: CURLF Debt, Cash & Liquidity
CURLF Revenue Growth, EPS Growth & YoY Performance
CURLF SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Curaleaf Holdings, Inc. (CIK: 0001756770)
❓ Frequently Asked Questions about CURLF
What is the AI rating for CURLF?
Curaleaf Holdings, Inc. (CURLF) has a Combined AI Rating of SELL from Claude (SELL) and ChatGPT (HOLD) with 86% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are CURLF's key strengths?
Claude: Operates in medicinal chemicals and botanical products sector with potential growth. OTC listing suggests market awareness. ChatGPT: Gross margin improved to 50% in 2025 from 48% in 2024, showing better production efficiency and cost control. Operating cash flow from continuing operations remained strong at about $152 million, supporting capital spending and debt servicing.
What are the risks of investing in CURLF?
Claude: Critical absence of financial data - no revenue, income, assets, or cash flow reporting visible. Data freshness shows None - indicates outdated or missing SEC filings. ChatGPT: Net loss attributable to Curaleaf widened to about $231 million, indicating that operating profitability is still not translating into bottom-line earnings. Uncertain tax position rose to roughly $532 million, creating major regulatory and cash flow risk if the company’s tax position is challenged.
What is CURLF's revenue and growth?
Curaleaf Holdings, Inc. reported revenue of N/A.
Does CURLF pay dividends?
Curaleaf Holdings, Inc. does not currently pay dividends.
Where can I find CURLF SEC filings?
Official SEC filings for Curaleaf Holdings, Inc. (CIK: 0001756770) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CURLF's EPS?
Curaleaf Holdings, Inc. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is CURLF a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Curaleaf Holdings, Inc. has a SELL rating with 86% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is CURLF stock overvalued or undervalued?
Valuation metrics for CURLF: ROE of N/A (sector avg: 14%), net margin of N/A (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
Should I buy CURLF stock in 2026?
Our dual AI analysis gives Curaleaf Holdings, Inc. a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is CURLF's free cash flow?
Curaleaf Holdings, Inc.'s operating cash flow is N/A, with capital expenditures of N/A.
How does CURLF compare to other Materials stocks?
Vs Materials sector averages: Net margin N/A (avg: 10%), ROE N/A (avg: 14%), current ratio N/A (avg: 1.6).